These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32309939)

  • 21. Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis.
    Zhu T; Cao S; Su PC; Patel R; Shah D; Chokshi HB; Szukala R; Johnson ME; Hevener KE
    J Med Chem; 2013 Sep; 56(17):6560-72. PubMed ID: 23688234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of virtual and high throughput screening in lead discovery settings.
    Polgár T; Keseru GM
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):889-97. PubMed ID: 21843143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Libraries: Recent Advances and Their Applications in Drug Discovery.
    Gong Z; Hu G; Li Q; Liu Z; Wang F; Zhang X; Xiong J; Li P; Xu Y; Ma R; Chen S; Li J
    Curr Drug Discov Technol; 2017; 14(4):216-228. PubMed ID: 28443514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Lead Generation.
    Holenz J; Stoy P
    Bioorg Med Chem Lett; 2019 Feb; 29(4):517-524. PubMed ID: 30606700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creating a more strategic small molecule biophysical hit characterization workflow.
    Fotsch C; Basu D; Case R; Chen Q; Koneru PC; Lo MC; Ngo R; Sharma P; Vaish A; Yi X; Zech SG; Hodder P
    SLAS Discov; 2024 Jun; 29(4):100159. PubMed ID: 38723666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries.
    Foley TL; Burchett W; Chen Q; Flanagan ME; Kapinos B; Li X; Montgomery JI; Ratnayake AS; Zhu H; Peakman MC
    SLAS Discov; 2021 Feb; 26(2):263-280. PubMed ID: 33412987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximizing the integration of virtual and experimental screening in hit discovery.
    Bajusz D; Keserű GM
    Expert Opin Drug Discov; 2022 Jun; 17(6):629-640. PubMed ID: 35671403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification.
    Bamborough P; Chung CW; Demont EH; Bridges AM; Craggs PD; Dixon DP; Francis P; Furze RC; Grandi P; Jones EJ; Karamshi B; Locke K; Lucas SCC; Michon AM; Mitchell DJ; Pogány P; Prinjha RK; Rau C; Roa AM; Roberts AD; Sheppard RJ; Watson RJ
    J Med Chem; 2019 Aug; 62(16):7506-7525. PubMed ID: 31398032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR screening and hit validation in fragment based drug discovery.
    Campos-Olivas R
    Curr Top Med Chem; 2011; 11(1):43-67. PubMed ID: 20809889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
    Hevener KE
    Methods Mol Biol; 2018; 1800():275-285. PubMed ID: 29934898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
    Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
    Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of estrogen receptor α ligands with virtual screening techniques.
    Niinivehmas SP; Manivannan E; Rauhamäki S; Huuskonen J; Pentikäinen OT
    J Mol Graph Model; 2016 Mar; 64():30-39. PubMed ID: 26774287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.